SBL induces cell death on ER-positive breast tumors but not on ER-negative breast tumors through down-regulation of ER and Bcl-2. The anti-cancer effect on SBL-treated ER-positive breast tumors is related to Bcl-2 overexpression, but not to Bcl-XL overexpression. The gene discussed is BCL2L1; the disease is cancer.